PFIZER INC (PFE.DE) Stock Fundamental Analysis
FRA:PFE - US7170811035 - Common Stock
21.045 EUR
+0.02 (+0.07%)
We assign a fundamental rating of 5 out of 10 to PFE. PFE was compared to 50 industry peers in the Pharmaceuticals industry. PFE has a medium profitability rating, but doesn't score so well on its financial health evaluation. PFE may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year PFE was profitable.
PFE had a positive operating cash flow in the past year.
PFE had positive earnings in each of the past 5 years.
In the past 5 years PFE always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 5.22%, PFE perfoms like the industry average, outperforming 48.00% of the companies in the same industry.
PFE has a Return On Equity of 12.12%. This is comparable to the rest of the industry: PFE outperforms 56.00% of its industry peers.
The Return On Invested Capital of PFE (7.61%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for PFE is below the industry average of 14.78%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 12.12% | ||
| ROIC | 7.61% |
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.06%
ROIC(5y)9.93%
1.3 Margins
The Profit Margin of PFE (16.84%) is better than 68.00% of its industry peers.
In the last couple of years the Profit Margin of PFE has declined.
PFE's Operating Margin of 28.52% is fine compared to the rest of the industry. PFE outperforms 80.00% of its industry peers.
PFE's Operating Margin has improved in the last couple of years.
The Gross Margin of PFE (73.96%) is better than 72.00% of its industry peers.
In the last couple of years the Gross Margin of PFE has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.52% | ||
| PM (TTM) | 16.84% | ||
| GM | 73.96% |
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
2. Health
2.1 Basic Checks
PFE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
PFE has more shares outstanding than it did 1 year ago.
PFE has more shares outstanding than it did 5 years ago.
PFE has a better debt/assets ratio than last year.
2.2 Solvency
PFE has an Altman-Z score of 2.15. This is not the best score and indicates that PFE is in the grey zone with still only limited risk for bankruptcy at the moment.
PFE has a Altman-Z score (2.15) which is in line with its industry peers.
The Debt to FCF ratio of PFE is 4.97, which is a neutral value as it means it would take PFE, 4.97 years of fcf income to pay off all of its debts.
PFE has a Debt to FCF ratio (4.97) which is in line with its industry peers.
PFE has a Debt/Equity ratio of 0.65. This is a neutral value indicating PFE is somewhat dependend on debt financing.
PFE's Debt to Equity ratio of 0.65 is in line compared to the rest of the industry. PFE outperforms 44.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 4.97 | ||
| Altman-Z | 2.15 |
ROIC/WACC0.84
WACC9.06%
2.3 Liquidity
A Current Ratio of 1.16 indicates that PFE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.16, PFE is doing worse than 66.00% of the companies in the same industry.
A Quick Ratio of 0.85 indicates that PFE may have some problems paying its short term obligations.
The Quick ratio of PFE (0.85) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 151.11% over the past year.
The Earnings Per Share has been growing slightly by 1.06% on average over the past years.
PFE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.54%.
Measured over the past years, PFE shows a quite strong growth in Revenue. The Revenue has been growing by 9.10% on average per year.
EPS 1Y (TTM)151.11%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%30%
Revenue 1Y (TTM)13.54%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%10.31%
3.2 Future
The Earnings Per Share is expected to decrease by -4.48% on average over the next years.
PFE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.85% yearly.
EPS Next Y0.26%
EPS Next 2Y0.86%
EPS Next 3Y0.2%
EPS Next 5Y-4.48%
Revenue Next Year0.29%
Revenue Next 2Y-0.22%
Revenue Next 3Y-0.8%
Revenue Next 5Y-2.85%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 7.26, the valuation of PFE can be described as very cheap.
Based on the Price/Earnings ratio, PFE is valued cheaply inside the industry as 88.00% of the companies are valued more expensively.
PFE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.06.
Based on the Price/Forward Earnings ratio of 7.78, the valuation of PFE can be described as very cheap.
Based on the Price/Forward Earnings ratio, PFE is valued cheaply inside the industry as 88.00% of the companies are valued more expensively.
PFE is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.26 | ||
| Fwd PE | 7.78 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PFE indicates a rather cheap valuation: PFE is cheaper than 82.00% of the companies listed in the same industry.
PFE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PFE is cheaper than 86.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.25 | ||
| EV/EBITDA | 7.07 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PFE does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)27.89
PEG (5Y)6.83
EPS Next 2Y0.86%
EPS Next 3Y0.2%
5. Dividend
5.1 Amount
PFE has a Yearly Dividend Yield of 7.01%, which is a nice return.
Compared to an average industry Dividend Yield of 3.06, PFE pays a better dividend. On top of this PFE pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, PFE pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.01% |
5.2 History
The dividend of PFE has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
PFE pays out 89.68% of its income as dividend. This is not a sustainable payout ratio.
PFE's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP89.68%
EPS Next 2Y0.86%
EPS Next 3Y0.2%
FRA:PFE (9/8/2025, 5:20:04 PM)
21.045
+0.02 (+0.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners67.51%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap119.65B
Analysts70.67
Price Target25.61 (21.69%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.01% |
Yearly Dividend1.44
Dividend Growth(5Y)3.3%
DP89.68%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.18%
Min EPS beat(2)32.91%
Max EPS beat(2)37.45%
EPS beat(4)4
Avg EPS beat(4)43.14%
Min EPS beat(4)32.52%
Max EPS beat(4)69.69%
EPS beat(8)8
Avg EPS beat(8)56.64%
EPS beat(12)12
Avg EPS beat(12)44.11%
EPS beat(16)16
Avg EPS beat(16)37.53%
Revenue beat(2)1
Avg Revenue beat(2)2.3%
Min Revenue beat(2)-2.36%
Max Revenue beat(2)6.96%
Revenue beat(4)3
Avg Revenue beat(4)5.79%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)17.22%
Revenue beat(8)5
Avg Revenue beat(8)3.23%
Revenue beat(12)8
Avg Revenue beat(12)3.35%
Revenue beat(16)11
Avg Revenue beat(16)3.45%
PT rev (1m)0.9%
PT rev (3m)-0.43%
EPS NQ rev (1m)-18.83%
EPS NQ rev (3m)-23.17%
EPS NY rev (1m)2.96%
EPS NY rev (3m)1.8%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)1.1%
Revenue NY rev (3m)1.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.26 | ||
| Fwd PE | 7.78 | ||
| P/S | 2.19 | ||
| P/FCF | 11.25 | ||
| P/OCF | 9.22 | ||
| P/B | 1.58 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.07 |
EPS(TTM)2.9
EY13.78%
EPS(NY)2.7
Fwd EY12.85%
FCF(TTM)1.87
FCFY8.89%
OCF(TTM)2.28
OCFY10.85%
SpS9.6
BVpS13.34
TBVpS-4.96
PEG (NY)27.89
PEG (5Y)6.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 12.12% | ||
| ROCE | 10.81% | ||
| ROIC | 7.61% | ||
| ROICexc | 8.26% | ||
| ROICexgc | 38.29% | ||
| OM | 28.52% | ||
| PM (TTM) | 16.84% | ||
| GM | 73.96% | ||
| FCFM | 19.48% |
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.06%
ROIC(5y)9.93%
ROICexc(3y)11.54%
ROICexc(5y)11.73%
ROICexgc(3y)46.07%
ROICexgc(5y)42.74%
ROCE(3y)14.48%
ROCE(5y)14.24%
ROICexcg growth 3Y-10.89%
ROICexcg growth 5Y27.11%
ROICexc growth 3Y-24.53%
ROICexc growth 5Y9.97%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
F-Score7
Asset Turnover0.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 4.97 | ||
| Debt/EBITDA | 2.3 | ||
| Cap/Depr | 40.51% | ||
| Cap/Sales | 4.31% | ||
| Interest Coverage | 5.77 | ||
| Cash Conversion | 60.76% | ||
| Profit Quality | 115.66% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 2.15 |
F-Score7
WACC9.06%
ROIC/WACC0.84
Cap/Depr(3y)55.83%
Cap/Depr(5y)55.63%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.87%
Profit Quality(3y)143.88%
Profit Quality(5y)138.86%
High Growth Momentum
Growth
EPS 1Y (TTM)151.11%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%30%
EPS Next Y0.26%
EPS Next 2Y0.86%
EPS Next 3Y0.2%
EPS Next 5Y-4.48%
Revenue 1Y (TTM)13.54%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%10.31%
Revenue Next Year0.29%
Revenue Next 2Y-0.22%
Revenue Next 3Y-0.8%
Revenue Next 5Y-2.85%
EBIT growth 1Y65.39%
EBIT growth 3Y-15.3%
EBIT growth 5Y12.71%
EBIT Next Year23.41%
EBIT Next 3Y6.93%
EBIT Next 5Y3.57%
FCF growth 1Y16.62%
FCF growth 3Y-30.95%
FCF growth 5Y-0.32%
OCF growth 1Y4.31%
OCF growth 3Y-26.87%
OCF growth 5Y0.25%